Literature DB >> 16407392

Anti-saccharomyces cerevisiae antibodies (ASCA) in coeliac disease.

A Granito, L Muratori, P Muratori, M Guidi, M Lenzi, F B Bianchi, U Volta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16407392      PMCID： PMC1856514     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  6 in total

1.  Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet.

Authors:  A Granito; D Zauli; P Muratori; L Muratori; A Grassi; R Bortolotti; N Petrolini; L Veronesi; P Gionchetti; F B Bianchi; U Volta
Journal:  Aliment Pharmacol Ther       Date:  2005-04-01       Impact factor: 8.171

2.  Serological markers identify histologically latent coeliac disease among first-degree relatives.

Authors:  H Vazquez; A Cabanne; E Sugai; A Fiorini; S Pedreira; E Mauriño; E Smecuol; R Dezi; S Niveloni; J Valero; S De Rosa; N Litwin; Z Kogan; L A Boerr; J C Bai
Journal:  Eur J Gastroenterol Hepatol       Date:  1996-01       Impact factor: 2.566

Review 3.  Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum.

Authors:  A Fasano; C Catassi
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

4.  Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.

Authors:  P Muratori; L Muratori; M Guidi; S Maccariello; G Pappas; R Ferrari; P Gionchetti; M Campieri; F B Bianchi
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

5.  Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease.

Authors:  R M van Elburg; J J Uil; C J Mulder; H S Heymans
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

6.  Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function.

Authors:  M G Clemente; S De Virgiliis; J S Kang; R Macatagney; M P Musu; M R Di Pierro; S Drago; M Congia; A Fasano
Journal:  Gut       Date:  2003-02       Impact factor: 23.059
  6 in total
  10 in total

1.  Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis.

Authors:  Sonja Lang; Yi Duan; Jinyuan Liu; Manolito G Torralba; Claire Kuelbs; Meritxell Ventura-Cots; Juan G Abraldes; Francisco Bosques-Padilla; Elizabeth C Verna; Robert S Brown; Victor Vargas; Jose Altamirano; Juan Caballería; Debbie Shawcross; Michael R Lucey; Alexandre Louvet; Philippe Mathurin; Guadalupe Garcia-Tsao; Samuel B Ho; Xin M Tu; Ramon Bataller; Peter Stärkel; Derrick E Fouts; Bernd Schnabl
Journal:  Hepatology       Date:  2019-08-20       Impact factor: 17.425

2.  Serum antibodies to Mycobacterium avium subspecies paratuberculosis combined with anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients: prevalence and diagnostic role.

Authors:  Franck Biet; Laurent Gendt; Eric Anton; Eric Ballot; Jean-Pierre Hugot; Catherine Johanet
Journal:  Dig Dis Sci       Date:  2011-01-08       Impact factor: 3.199

Review 3.  Glucocorticosteroids and the Risk of NAFLD in Inflammatory Bowel Disease.

Authors:  Sara Jarmakiewicz-Czaja; Aneta Sokal; Piotr Pardak; Rafał Filip
Journal:  Can J Gastroenterol Hepatol       Date:  2022-05-11

4.  Presence of anti-microbial antibodies in liver cirrhosis--a tell-tale sign of compromised immunity?

Authors:  Maria Papp; Gary L Norman; Zsuzsanna Vitalis; Istvan Tornai; Istvan Altorjay; Ildiko Foldi; Miklos Udvardy; Zakera Shums; Tamas Dinya; Peter Orosz; Bela Lombay; Gabriella Par; Alajos Par; Gabor Veres; Timea Csak; Janos Osztovits; Ferenc Szalay; Peter Laszlo Lakatos
Journal:  PLoS One       Date:  2010-09-23       Impact factor: 3.240

5.  Anti-microbial antibodies in celiac disease: trick or treat?

Authors:  Maria Papp; Ildiko Foldi; Istvan Altorjay; Eszter Palyu; Miklos Udvardy; Judit Tumpek; Sandor Sipka; Ilma Rita Korponay-Szabo; Eva Nemes; Gabor Veres; Tamas Dinya; Attila Tordai; Hajnalka Andrikovics; Gary L Norman; Peter Laszlo Lakatos
Journal:  World J Gastroenterol       Date:  2009-08-21       Impact factor: 5.742

6.  Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease.

Authors:  Sara Ashorn; Hanna Raukola; Tuuli Välineva; Merja Ashorn; Bo Wei; Jonathan Braun; Immo Rantala; Katri Kaukinen; Tiina Luukkaala; Pekka Collin; Markku Mäki; Sari Iltanen
Journal:  J Clin Immunol       Date:  2008-05-22       Impact factor: 8.317

7.  Midkine in vitamin D deficiency and its association with anti-Saccharomyces cerevisiae antibodies.

Authors:  F B Serinkan Cinemre; Hakan Cinemre; Cengiz Karacaer; Birsen Aydemir; Ahmet Nalbant; Tezcan Kaya; Ali Tamer
Journal:  Inflamm Res       Date:  2015-11-13       Impact factor: 4.575

8.  Clinical Significance of Novel Neutrophil-Based Biomarkers in the Diagnosis and Prediction of Response to Infliximab Therapy in Crohn's Disease.

Authors:  Zhou Zhou; Yinghui Zhang; Xue Yang; Yan Pan; Liangping Li; Caiping Gao; Chong He
Journal:  Front Immunol       Date:  2022-03-04       Impact factor: 7.561

9.  Research hotspot and trend analysis in the diagnosis of inflammatory bowel disease: A machine learning bibliometric analysis from 2012 to 2021.

Authors:  Chuan Liu; Rong Yu; Jixiang Zhang; Shuchun Wei; Fumin Xue; Yingyun Guo; Pengzhan He; Lining Shang; Weiguo Dong
Journal:  Front Immunol       Date:  2022-09-14       Impact factor: 8.786

Review 10.  Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation.

Authors:  Lumir Kunovsky; Petr Dite; Petr Jabandziev; Zdenek Kala; Jitka Vaculova; Tomas Andrasina; Matej Hrunka; Martina Bojkova; Jan Trna
Journal:  J Clin Med       Date:  2021-12-11       Impact factor: 4.241
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.